Sorrento Therapeutics, Inc.
Antigen binding proteins that bind PD-L1
Last updated:
Abstract:
There is disclosed anti-PD-L1 IgG class antibodies that have an improved ability to be manufactured at higher yields. More specifically, there is disclosed human antibodies that bind PD-L1, PD-L1-binding fragments that can be manufactured at higher yields.
Status:
Grant
Type:
Utility
Filling date:
10 Oct 2018
Issue date:
16 Feb 2021